Ameritas Investment Partners’s Forte Biosciences FBRX Stock Holding History

Ameritas Investment Partners’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.4K	Buy	+1,758	New	+$41.7K	﹤0.01%	2433
2022 Q2	–	Sell	-35	Closed	-$1K	–	3122
2022 Q1	$1K	Hold	35	–	–	﹤0.01%	3062
2021 Q4	$2K	Hold	35	–	–	﹤0.01%	3092
2021 Q3	$3K	Hold	35	–	–	﹤0.01%	3062
2021 Q2	$30K	Buy	+35	New	+$31.5K	﹤0.01%	2498
2020 Q2	–	Sell	-4	Closed	-$2K	–	3086
2020 Q1	$2K	Hold	4	–	–	﹤0.01%	2962
2019 Q4	$1K	Hold	4	–	–	﹤0.01%	2996
2019 Q3	$1K	Hold	4	–	–	﹤0.01%	3044
2019 Q2	$10K	Hold	4	–	–	﹤0.01%	2800
2019 Q1	$17K	Hold	4	–	–	﹤0.01%	2456
2018 Q4	$13K	Hold	4	–	–	﹤0.01%	2552
2018 Q3	$24K	Hold	4	–	–	﹤0.01%	2413
2018 Q2	$14K	Hold	4	–	–	﹤0.01%	2692
2018 Q1	$18K	Hold	4	–	–	﹤0.01%	2470
2017 Q4	$16K	Buy	4 +2	+100%	+$7.98K	﹤0.01%	2543
2017 Q3	$10K	Hold	2	–	–	﹤0.01%	2766
2017 Q2	$9K	Buy	+2	New	+$11.3K	﹤0.01%	2840

Other funds holding FBRX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Ameritas Investment Partners's FBRX Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Forte Biosciences (FBRX) in Q2 2026: 1,758 shares worth $37.4K. The stake represents ﹤0.01% of the portfolio and ranks #2433 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in FBRX as recently as Q1 2022.

Ameritas Investment Partners first reported a position in FBRX in Q2 2017 and has held it in 17 quarters since. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

Ameritas Investment Partners held 1,758 shares of Forte Biosciences worth $37.4K as of Q2 2026.
Forte Biosciences was a new Ameritas Investment Partners position in Q2 2026.
Forte Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2433 holding.
Ameritas Investment Partners first reported a position in Forte Biosciences in Q2 2017 and has held it in 17 quarters since.
86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.